These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 8615657
21. In vitro sequence-dependent interaction between nedaplatin and paclitaxel in human cancer cell lines. Tanaka R, Takii Y, Shibata Y, Ariyama H, Qin B, Baba E, Kusaba H, Mitsugi K, Harada M, Nakano S. Cancer Chemother Pharmacol; 2005 Sep; 56(3):279-85. PubMed ID: 15875187 [Abstract] [Full Text] [Related]
22. In vitro concurrent paclitaxel and radiation of four vulvar squamous cell carcinoma cell lines. Jaakkola M, Rantanen V, Grénman S, Kulmala J, Grénman R. Cancer; 1996 May 01; 77(9):1940-6. PubMed ID: 8646696 [Abstract] [Full Text] [Related]
23. S100P sensitizes ovarian cancer cells to carboplatin and paclitaxel in vitro. Wang Q, He Z, Gao J, Hu S, Huang M, Liu M, Zheng J, Tang H. Cancer Lett; 2008 Dec 18; 272(2):277-84. PubMed ID: 18762368 [Abstract] [Full Text] [Related]
24. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model. Horowitz NS, Hua J, Gibb RK, Mutch DG, Herzog TJ. Gynecol Oncol; 2004 Jul 18; 94(1):67-73. PubMed ID: 15262121 [Abstract] [Full Text] [Related]
25. Comparative evaluation of cisplatin and carboplatin sensitivity in endometrial adenocarcinoma cell lines. Rantanen V, Grénman S, Kulmala J, Grénman R. Br J Cancer; 1994 Mar 18; 69(3):482-6. PubMed ID: 8123477 [Abstract] [Full Text] [Related]
26. Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy. Keshelava N, Seeger RC, Groshen S, Reynolds CP. Cancer Res; 1998 Dec 01; 58(23):5396-405. PubMed ID: 9850071 [Abstract] [Full Text] [Related]
32. In vitro antiproliferative activity of docetaxel (Taxotere), paclitaxel (Taxol) and cisplatin against human tumour and normal bone marrow cells. Braakhuis BJ, Hill BT, Dietel M, Kelland LR, Aapro MS, Zoli W, Lelieveld P. Anticancer Res; 1994 Dec 01; 14(1A):205-8. PubMed ID: 7909419 [Abstract] [Full Text] [Related]
33. Differential sensitivity to paclitaxel-induced apoptosis and growth suppression in paclitaxel-resistant cell lines established from HEC-1 human endometrial adenocarcinoma cells. Tanaka T, Toujima S, Tanaka J. Int J Oncol; 2012 Nov 01; 41(5):1837-44. PubMed ID: 22923148 [Abstract] [Full Text] [Related]
34. In vitro sensitivity of human endometrial cancer cell lines to paclitaxel or irinotecan (CPT-11) in combination with other aniticancer drugs. Hiramatsu HP, Kikuchi Y, Seto H, Nagata I. Anticancer Drugs; 2000 Aug 01; 11(7):573-8. PubMed ID: 11036961 [Abstract] [Full Text] [Related]
35. Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and -resistant human ovarian carcinoma cell lines. Kelland LR, Abel G. Cancer Chemother Pharmacol; 1992 Aug 01; 30(6):444-50. PubMed ID: 1356649 [Abstract] [Full Text] [Related]
36. Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines. Gentilin E, Minoia M, Bondanelli M, Tagliati F, Degli Uberti EC, Zatelli MC. Endocrine; 2017 Jun 01; 56(3):621-632. PubMed ID: 27585662 [Abstract] [Full Text] [Related]
37. [Antitumor effect of docetaxel against human endometrial tumor cell lines]. Shakuto S, Noguchi K, Bissery MC. Gan To Kagaku Ryoho; 2005 Oct 01; 32(10):1437-42. PubMed ID: 16227744 [Abstract] [Full Text] [Related]
38. The steroidogenic and morphological effects of paclitaxel on cultured ovarian cancer cells. Cameron MR, Caudle MR, Sullivan WR, Peluso JJ, Wimalasena J. Oncol Res; 1995 Oct 01; 7(3-4):145-56. PubMed ID: 8555648 [Abstract] [Full Text] [Related]
39. Paclitaxel, Carboplatin and 1,25-D3 Inhibit Proliferation of Endometrial Cancer Cells In Vitro. Kuittinen T, Rovio P, Staff S, Luukkaala T, Kallioniemi A, Grénman S, Laurila M, Mäenpää J. Anticancer Res; 2017 Dec 01; 37(12):6575-6581. PubMed ID: 29187432 [Abstract] [Full Text] [Related]
40. Comparison of in vitro methods for assessing cytotoxic activity against two pancreatic adenocarcinoma cell lines. Chang BK. Cancer Res; 1983 Jul 01; 43(7):3147-9. PubMed ID: 6850624 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]